Clinical Performance of a Silicone Hydrogel Contact Lens Following Six Nights of Extended Wear
NCT ID: NCT03614130
Last Updated: 2021-09-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2018-08-23
2018-09-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
NCT03560141
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
NCT03586167
Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens
NCT04207749
Clinical Evaluation of a Daily Wear Frequent Replacement Silicone Hydrogel Lens
NCT03920280
Clinical Evaluation of a Silicone Hydrogel Daily Wear Monthly Replacement Contact Lens
NCT04422990
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LID011121 (OD) / Biofinity (OS)
LID011121 contact lens worn in the right eye, with comfilcon A contact lens worn in the left eye, as randomized, for approximately 6 nights of extended (overnight) wear
LID011121 contact lens
Investigational silicone hydrogel contact lens
Comfilcon A contact lens
Commercially available silicone hydrogel contact lens
Biofinity (OD) / LID011121 (OS)
Comfilcon A contact lens worn in the right eye, with LID011121 contact lens worn in the left eye, as randomized, for approximately 6 nights of extended (overnight) wear
LID011121 contact lens
Investigational silicone hydrogel contact lens
Comfilcon A contact lens
Commercially available silicone hydrogel contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LID011121 contact lens
Investigational silicone hydrogel contact lens
Comfilcon A contact lens
Commercially available silicone hydrogel contact lens
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Successful wear of spherical soft contact lenses in both eyes during the past 3 months for a minimum of 5 days per week and in an extended wear modality a minimum of 1 night per week.
* Best Corrected Visual Acuity (BCVA) of 20/25 or better in each eye.
Exclusion Criteria
* Current Biofinity© lens wearer.
* Pregnant or breast-feeding.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CDMA Project Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Investigative Site
Johns Creek, Georgia, United States
Alcon Investigative Site
Brentwood, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLL949-C005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.